A new journey to predict the prognosis of diabetic kidney disease.
作者信息
Kim Da Woon, Song Sang Heon
机构信息
Department of Internal Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, Republic of Korea.
出版信息
Kidney Res Clin Pract. 2023 Jul;42(4):409-411. doi: 10.23876/j.krcp.23.093. Epub 2023 Jul 28.
Abstract
摘要
相似文献
1
A new journey to predict the prognosis of diabetic kidney disease.预测糖尿病肾病预后的新征程。
Kidney Res Clin Pract. 2023 Jul;42(4):409-411. doi: 10.23876/j.krcp.23.093. Epub 2023 Jul 28.
2
Development and validation of a novel nomogram to predict diabetic kidney disease in patients with type 2 diabetic mellitus and proteinuric kidney disease.开发和验证一种新的列线图模型以预测 2 型糖尿病合并蛋白尿性肾病患者的糖尿病肾脏疾病。
Int Urol Nephrol. 2023 Jan;55(1):191-200. doi: 10.1007/s11255-022-03299-x. Epub 2022 Jul 23.
3
Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease.使用易于获取的炎症标志物预测糖尿病肾病
Front Endocrinol (Lausanne). 2018 May 22;9:225. doi: 10.3389/fendo.2018.00225. eCollection 2018.
4
An evaluation of the diabetic kidney disease definition in chinese patients diagnosed with type 2 diabetes mellitus.对诊断为2型糖尿病的中国患者糖尿病肾病定义的评估。
J Int Med Res. 2009 Sep-Oct;37(5):1493-500. doi: 10.1177/147323000903700526.
5
Nonproteinuric diabetic kidney disease.非蛋白尿型糖尿病肾病。
Clin Exp Nephrol. 2020 Jul;24(7):573-581. doi: 10.1007/s10157-020-01881-0. Epub 2020 Mar 31.
6
Prognosis and risk factors of chronic kidney disease progression in patients with diabetic kidney disease and non-diabetic kidney disease: a prospective cohort CKD-ROUTE study.患有糖尿病肾病和非糖尿病肾病的患者慢性肾脏病进展的预后和危险因素：一项前瞻性队列 CKD-ROUTE 研究。
Ren Fail. 2022 Dec;44(1):1309-1318. doi: 10.1080/0886022X.2022.2106872.
7
The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.在经活检证实的 2 型糖尿病合并糖尿病肾脏疾病患者中，肾小管间质标志物在鉴别诊断和预后中的作用。
Clin Chim Acta. 2023 Jul 1;547:117448. doi: 10.1016/j.cca.2023.117448. Epub 2023 Jun 17.
8
Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.2 型糖尿病患者肾病预测模型的性能：系统评价和外部验证研究。
BMJ. 2021 Sep 28;374:n2134. doi: 10.1136/bmj.n2134.
9
[Artificial intelligence: a new journey in nephrology].[人工智能：肾脏病学的新征程]
Zhonghua Yi Xue Za Zhi. 2023 May 16;103(18):1355-1358. doi: 10.3760/cma.j.cn112137-20221201-02537.
10
Kidney injury molecule-1 as a predicting factor for inflamed kidney, diabetic and diabetic nephropathy Egyptian patients.肾损伤分子-1作为埃及炎症性肾病、糖尿病及糖尿病肾病患者的预测因子
J Diabetes Metab Disord. 2015 Feb 25;14:6. doi: 10.1186/s40200-015-0131-8. eCollection 2015.
引用本文的文献
1
Clinical implications of proximal tubular multicilia in glomerular diseases.近端肾小管多纤毛在肾小球疾病中的临床意义
Heliyon. 2025 Feb 1;11(3):e42416. doi: 10.1016/j.heliyon.2025.e42416. eCollection 2025 Feb 15.
2
The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease.载脂蛋白 C-III 在心肾疾病中的作用及其调控机制
Diabetologia. 2024 Sep;67(9):1980-1997. doi: 10.1007/s00125-024-06191-8. Epub 2024 Jun 15.
3
Periostin deficiency attenuates kidney fibrosis in diabetic nephropathy by improving pancreatic β-cell dysfunction and reducing kidney EMT.骨桥蛋白缺失通过改善胰岛β细胞功能障碍和减少肾脏 EMT 来减轻糖尿病肾病中的肾纤维化。
Sci Rep. 2023 Oct 16;13(1):17599. doi: 10.1038/s41598-023-44177-5.
本文引用的文献
1
Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance.尿肌醇作为糖尿病肾病的一种新型预后生物标志物：一项使用核磁共振的靶向代谢组学研究
Kidney Res Clin Pract. 2023 Jul;42(4):445-459. doi: 10.23876/j.krcp.22.152. Epub 2023 Jul 25.
2
Potential progression biomarkers of diabetic kidney disease determined using comprehensive machine learning analysis of non-targeted metabolomics.利用非靶向代谢组学的综合机器学习分析确定糖尿病肾病的潜在进展生物标志物。
Sci Rep. 2022 Sep 29;12(1):16287. doi: 10.1038/s41598-022-20638-1.
3
Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs.肾小球滤过率作为糖尿病肾病的肾脏结局：关注新型抗糖尿病药物。
Korean J Intern Med. 2022 May;37(3):502-519. doi: 10.3904/kjim.2021.515. Epub 2022 Apr 4.
4
Differential Urinary Proteome Analysis for Predicting Prognosis in Type 2 Diabetes Patients with and without Renal Dysfunction.2 型糖尿病合并与不合并肾功能障碍患者的尿差异蛋白质组学分析及其对预后的预测价值。
Int J Mol Sci. 2020 Jun 14;21(12):4236. doi: 10.3390/ijms21124236.
5
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.糖尿病患者肾功能下降的代谢组学标志物：来自慢性肾功能不全队列（CRIC）研究的证据。
Am J Kidney Dis. 2020 Oct;76(4):511-520. doi: 10.1053/j.ajkd.2020.01.019. Epub 2020 May 5.
6
Progressive Decline in Estimated Glomerular Filtration Rate in Patients With Diabetes After Moderate Loss in Kidney Function-Even Without Albuminuria.肾功能中度下降后糖尿病患者估算肾小球滤过率的进行性下降-甚至没有白蛋白尿。
Diabetes Care. 2019 Oct;42(10):1886-1894. doi: 10.2337/dc19-0349. Epub 2019 Jun 20.
7
Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.糖尿病中的肾小球高滤过：机制、临床意义及治疗
J Am Soc Nephrol. 2017 Apr;28(4):1023-1039. doi: 10.1681/ASN.2016060666. Epub 2017 Jan 31.
8
Uremic solutes and risk of end-stage renal disease in type 2 diabetes: metabolomic study.2型糖尿病中尿毒症溶质与终末期肾病风险：代谢组学研究
Kidney Int. 2014 May;85(5):1214-24. doi: 10.1038/ki.2013.497. Epub 2014 Jan 15.
9
A metabolomic study of low estimated GFR in non-proteinuric type 2 diabetes mellitus.非蛋白尿 2 型糖尿病患者估算肾小球滤过率低的代谢组学研究。
Diabetologia. 2012 Feb;55(2):499-508. doi: 10.1007/s00125-011-2339-6. Epub 2011 Oct 25.
Zotero 插件